Hydrocortisone with natamycin and neomycin cream (Pimafucort cream): Discontinuation
LEO Pharma is discontinuing this product as one of the ingredients used in the cream is no longer available.
1 February 2022: Pimafucort cream no longer available.
LEO Pharma has discontinued their Pimafucort brand of hydrocortisone with natamycin and neomycin cream. Pimafucort cream 15 g will not be available from 1 February 2022.
Supply of hydrocortisone with natamycin and neomycin ointment is unaffected and will remain available in New Zealand.
- 1 February 2022: Pimafucort cream 15 g (Pharmacode: 260266) discontinued.
- 1 May 2022: Pimafucort cream 15 g delisted from the Pharmaceutical Schedule.
Prescribers: What you need to know
Prescribers will need to use alternative treatments in the absence of Pimafucort cream. We have received clinical advice that suitable alternatives include:
- hydrocortisone with natamycin and neomycin ointment (p/code 260282)(external link)
- triamcinolone acetonide with gramicidin, neomycin and nystatin cream (P/code 2083078) (Note: partially subsidised)(external link)
If you know of any other suitable alternatives, contact us at firstname.lastname@example.org
Read the NZ Formulary monographs
Patients: Who to contact
If you use Pimafucort cream, talk to your pharmacist, doctor, or the person who prescribed this medicine. They know you best and can advise on the best alternative. Pharmac cannot comment on individual clinical circumstances.